ESLOY logo

EssilorLuxottica S.A. (ESLOY)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

EssilorLuxottica S.A. (ESLOY) with AI Score 49/100 (Weak). EssilorLuxottica S. A. is a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. Market cap: 0, Sector: Healthcare.

Last analyzed: Mar 16, 2026
EssilorLuxottica S.A. is a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. With a rich history dating back to 1849, the company operates across multiple segments, serving a vast network of customers worldwide.
49/100 AI Score

EssilorLuxottica S.A. (ESLOY) Healthcare & Pipeline Overview

CEOFrancesco Milleri
Employees153498
HeadquartersParis, FR
IPO Year2008

EssilorLuxottica S.A., a global leader in the eyewear industry, designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses. With a diverse brand portfolio and extensive global reach, the company caters to a wide range of consumer needs through its wholesale, retail, and equipment segments, maintaining a strong market position.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

EssilorLuxottica presents a compelling investment case based on its dominant market position and diverse product portfolio. With a market capitalization of $107.79 billion and a profit margin of 8.1%, the company demonstrates financial strength. Growth catalysts include expansion in emerging markets and continued innovation in lens technology. The company's beta of 0.55 suggests lower volatility compared to the market. However, a P/E ratio of 40.96 indicates a premium valuation, and investors may want to evaluate potential risks such as currency fluctuations and competitive pressures. The dividend yield of 1.93% provides a steady income stream.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $107.79B reflects EssilorLuxottica's dominant position in the eyewear market.
  • Gross Margin of 60.6% indicates strong pricing power and efficient operations.
  • Profit Margin of 8.1% demonstrates solid profitability in a competitive industry.
  • Dividend Yield of 1.93% provides a steady income stream for investors.
  • Beta of 0.55 suggests lower volatility compared to the broader market.

Competitors & Peers

Strengths

  • Global market leadership in eyewear.
  • Strong brand portfolio.
  • Vertically integrated supply chain.
  • Extensive distribution network.

Weaknesses

  • High debt levels.
  • Exposure to currency fluctuations.
  • Dependence on key brands.
  • Complex organizational structure.

Catalysts

  • Ongoing: Expansion into emerging markets, driving revenue growth.
  • Ongoing: Innovation in lens technology, enhancing product offerings.
  • Upcoming: Potential acquisitions of smaller eyewear companies, expanding market share.
  • Ongoing: Digital transformation initiatives, improving customer experience.
  • Ongoing: Partnerships with healthcare providers, increasing sales and referrals.

Risks

  • Potential: Economic downturns impacting consumer spending on eyewear.
  • Ongoing: Intense competition from other eyewear manufacturers.
  • Potential: Fluctuations in currency exchange rates affecting profitability.
  • Potential: Changes in consumer preferences and fashion trends.
  • Ongoing: Regulatory changes and compliance requirements.

Growth Opportunities

  • Expansion in Emerging Markets: EssilorLuxottica has significant growth potential in emerging markets such as China and India, where rising disposable incomes and increasing awareness of eye care are driving demand for eyewear products. The market size for eyewear in these regions is estimated to reach $30 billion by 2030, offering a substantial opportunity for EssilorLuxottica to expand its market share through strategic partnerships and targeted marketing campaigns.
  • Innovation in Lens Technology: Continued investment in research and development of advanced lens technologies, such as blue light filtering and personalized vision solutions, can drive growth for EssilorLuxottica. The market for advanced lens technologies is projected to reach $15 billion by 2028, and EssilorLuxottica's strong R&D capabilities position it to capture a significant share of this market.
  • Digital Transformation: Embracing digital technologies and expanding online sales channels can enhance EssilorLuxottica's reach and improve customer experience. The online eyewear market is growing rapidly, with an estimated market size of $20 billion by 2027. EssilorLuxottica can leverage its existing brands and distribution network to capitalize on this trend and drive online sales growth.
  • Strategic Acquisitions: Pursuing strategic acquisitions of smaller eyewear companies and brands can expand EssilorLuxottica's product portfolio and geographic reach. The eyewear industry is fragmented, with numerous small and medium-sized players. EssilorLuxottica can consolidate its market position through targeted acquisitions that complement its existing business and provide access to new markets and technologies.
  • Partnerships with Healthcare Providers: Collaborating with healthcare providers, such as optometrists and ophthalmologists, can drive referrals and increase sales of EssilorLuxottica's products. By offering comprehensive eye care solutions and partnering with trusted healthcare professionals, EssilorLuxottica can strengthen its brand reputation and build customer loyalty. This strategy can lead to increased market penetration and sustainable growth in the long term.

Opportunities

  • Expansion in emerging markets.
  • Growth in online sales channels.
  • Innovation in lens technology.
  • Strategic acquisitions.

Threats

  • Intense competition.
  • Changing consumer preferences.
  • Economic downturns.
  • Regulatory changes.

Competitive Advantages

  • Strong brand portfolio with well-known brands like Ray-Ban and Oakley.
  • Extensive global distribution network.
  • Vertically integrated business model.
  • Significant investment in research and development.

About ESLOY

EssilorLuxottica Société anonyme, established in 2018 through the merger of Essilor and Luxottica, traces its roots back to 1849. The company designs, manufactures, and distributes a wide array of ophthalmic lenses, frames, and sunglasses. Operating across North America, Europe, Latin America, Asia, Oceania, and Africa, EssilorLuxottica has a significant global footprint. Its operations are divided into five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment focuses on the manufacture and distribution of luxury and sports eyewear. The Retail segment retails these products through a network of stores. The Lenses and Optical Instruments segment offers a variety of lenses, including Varilux progressive lenses, Crizal anti-reflective lenses, and Transitions photochromic lenses, along with lens edging and mounting instruments. The Equipment segment provides digital surfacing and lens coating machines. The Sunglasses and Readers segment markets non-prescription sunglasses and reading glasses under various brands, including Foster Grant and Bolon. EssilorLuxottica's extensive network includes 490 prescription laboratories and edging-mounting facilities, solidifying its position as a leader in the eyewear industry.

What They Do

  • Designs and manufactures ophthalmic lenses.
  • Produces and distributes eyewear frames.
  • Markets and sells sunglasses.
  • Operates wholesale distribution networks for eyewear.
  • Runs retail stores selling eyewear products.
  • Develops and sells lens edging and mounting instruments.
  • Provides optometry instruments for eye care professionals.

Business Model

  • Manufacturing and selling ophthalmic lenses, frames, and sunglasses through wholesale channels.
  • Operating retail stores to sell eyewear directly to consumers.
  • Providing equipment and instruments for lens production and eye care.
  • Licensing brands for eyewear products.

Industry Context

EssilorLuxottica operates in the medical instruments and supplies industry, which is experiencing steady growth driven by an aging global population and increasing awareness of eye health. The company's competitive landscape includes players like CSLLY (Carl Zeiss Meditec), FSNUY (FUJIFILM Holdings), and HOCPY (HOYA Corp). EssilorLuxottica's vertically integrated business model and strong brand portfolio provide a competitive edge in capturing market share and driving growth.

Key Customers

  • Opticians and optometrists.
  • Retail consumers purchasing eyewear.
  • Prescription laboratories.
  • Eye care professionals and institutions.
AI Confidence: 82% Updated: Mar 16, 2026

Financials

Chart & Info

EssilorLuxottica S.A. (ESLOY) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ESLOY.

Price Targets

Wall Street price target analysis for ESLOY.

MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates ESLOY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Classification

Sector Healthcare Industry Medical - Instruments & Supplies

Competitors & Peers

Latest News

Leadership: Francesco Milleri

Chairman and CEO

Francesco Milleri has been with Luxottica since 2004, holding various leadership positions including CEO of Luxottica Group. His expertise spans technology, operations, and strategy. He played a crucial role in the merger between Essilor and Luxottica. Milleri is known for his data-driven approach and focus on innovation. He holds degrees in engineering and business administration.

Track Record: Under Milleri's leadership, EssilorLuxottica has focused on integrating its operations and driving innovation in eyewear technology. He has overseen the launch of new products and the expansion of the company's digital presence. Milleri has also emphasized sustainability and social responsibility initiatives. His strategic decisions have contributed to the company's continued growth and market leadership.

EssilorLuxottica S.A. ADR Information Unsponsored

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. ESLOY, as an ADR, allows U.S. investors to invest in EssilorLuxottica S.A. without the complexities of cross-border transactions. The ADR is denominated in U.S. dollars, simplifying trading and reporting for U.S. investors.

  • Home Market Ticker: Euronext Paris, France
  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: ESLO
Currency Risk: Investing in ESLOY exposes U.S. investors to currency risk, as the underlying shares are denominated in Euros. Fluctuations in the EUR/USD exchange rate can impact the value of the ADR and dividend payments. A stronger Euro increases the value of the ADR, while a weaker Euro decreases it.
Tax Implications: Dividends paid on ESLOY ADRs are subject to foreign dividend withholding tax in France. The standard withholding tax rate is typically 12.8%. However, the U.S. has a tax treaty with France that may reduce the withholding tax rate for eligible U.S. investors. Investors should consult with a tax advisor to determine their specific tax obligations.
Trading Hours: The Euronext Paris stock exchange operates from 9:00 AM to 5:30 PM Central European Time (CET), which is 3:00 AM to 11:30 AM Eastern Time (ET). This means there is a significant overlap with U.S. trading hours, but U.S. investors may need to trade during off-peak hours to capture full trading activity.

ESLOY OTC Market Information

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and potential for fraud or manipulation. These companies may be newly formed, distressed, or foreign entities seeking U.S. investor exposure without full compliance.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity for ESLOY on the OTC market is likely to be limited, with potentially low trading volume and wide bid-ask spreads. This can make it difficult to buy or sell shares at desired prices, especially in large quantities. Investors may experience significant price slippage and increased transaction costs due to the illiquidity of the OTC market.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in ESLOY.
  • Low trading volume and wide bid-ask spreads can lead to price volatility.
  • Potential for fraud or manipulation on the OTC market.
  • Lack of regulatory oversight and investor protection.
  • Higher risk of delisting or trading suspension.
Due Diligence Checklist:
  • Verify the company's registration and legal status.
  • Obtain and review audited financial statements.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive position.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Monitor the company's news and announcements for any red flags.
Legitimacy Signals:
  • EssilorLuxottica S.A. is a well-established global company with a long history.
  • The company has a strong brand portfolio and a significant market presence.
  • EssilorLuxottica is listed on the Euronext Paris stock exchange.
  • The company has a large employee base and a global network of operations.

Common Questions About ESLOY

What does EssilorLuxottica S.A. do?

EssilorLuxottica S.A. is the world leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. The company operates through a vertically integrated business model, encompassing wholesale distribution, retail stores, and equipment manufacturing. Its key products include Varilux progressive lenses, Crizal anti-reflective lenses, and a wide range of eyewear brands such as Ray-Ban, Oakley, and Persol. EssilorLuxottica serves a global customer base, including opticians, optometrists, and retail consumers.

What do analysts say about ESLOY stock?

Analyst consensus on ESLOY stock is generally positive, reflecting the company's strong market position and growth prospects. Key valuation metrics, such as P/E ratio and dividend yield, are closely monitored. Growth considerations include expansion in emerging markets, innovation in lens technology, and strategic acquisitions. However, analysts also caution about potential risks such as economic downturns and currency fluctuations. The stock's performance is influenced by broader market trends and industry-specific factors.

What are the main risks for ESLOY?

The main risks for EssilorLuxottica include economic downturns that could reduce consumer spending on eyewear, intense competition from other eyewear manufacturers, and fluctuations in currency exchange rates that could affect profitability. Additionally, changes in consumer preferences and fashion trends could impact demand for the company's products. Regulatory changes and compliance requirements also pose a risk, as they could increase operating costs and affect market access. The company's high debt levels are also a concern.

How does EssilorLuxottica S.A. navigate regulatory approval processes?

As a global manufacturer of medical devices (ophthalmic lenses and eyewear), EssilorLuxottica S.A. must comply with stringent regulatory requirements in various countries. In the United States, the company's products are subject to FDA approval, while in Europe, they must meet the standards of the European Medicines Agency (EMA). EssilorLuxottica maintains a dedicated regulatory affairs team that monitors and manages compliance with these regulations. The company has a track record of successfully navigating regulatory approval processes, and it invests in research and development to ensure its products meet the highest safety and quality standards. However, pending approvals and potential changes in regulations could impact the company's future performance.

What are the key growth opportunities for ESLOY in healthcare?

EssilorLuxottica S.A. has several key growth opportunities in the healthcare sector. One significant opportunity is the increasing prevalence of myopia (nearsightedness) worldwide, particularly in Asia. This trend is driving demand for corrective lenses and eyewear. Another growth area is the development of advanced lens technologies, such as blue light filtering lenses and personalized vision solutions, which cater to the growing needs of digital device users. Additionally, EssilorLuxottica can expand its partnerships with healthcare providers to offer comprehensive eye care solutions and increase sales of its products. The company's strong brand reputation and global distribution network position it well to capitalize on these opportunities.

What are the key factors to evaluate for ESLOY?

EssilorLuxottica S.A. (ESLOY) currently holds an AI score of 49/100, indicating low score. Key strength: Global market leadership in eyewear.. Primary risk to monitor: Potential: Economic downturns impacting consumer spending on eyewear.. This is not financial advice.

How frequently does ESLOY data refresh on this page?

ESLOY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ESLOY's recent stock price performance?

Recent price movement in EssilorLuxottica S.A. (ESLOY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Global market leadership in eyewear.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • OTC market data may be less reliable than exchange-listed data.
  • AI analysis pending for ESLOY.
Data Sources

Popular Stocks